Animal Testing And Non-Animal Alternative Testing Market - By Type (Animal Type, Industrial Application), Drivers, Restraints, Global Opportunities And Strategies – Global Forecast To 2035

Starting Price : $ 4000.00 $3200.00 | Pages : 290 | Published : March 2020 | SKU CODE : o&s113 | Format :

Request Sample

Animal Testing Market Definition

The animal testing market consists of the total expenses incurred by end-use entities that use animals for testing their products. End-use entities include academic research institutions and various industries (such as pharmaceuticals, medical devices, chemicals & pesticides and cosmetics,) that conduct animal testing during product development. Pharmaceutical and medical device companies also use animal testing to understand basic disease mechanisms. End-use entities may also outsource these tests to clinical research organizations (CROs). The animal testing market covered in this report includes sales of animal testing services by CROs to end use industries.

The market includes the costs of animal models and the costs of animal testing operations (such as animal maintenance and feed) during drug/ product testing. This market does not include animals caged in companies as stock and not used for testing, and animals used for breeding.

Non-Animal Alternative Testing Market Definition

The non-animal alternative testing market is the total expenses incurred by end-use entities that use alternative technologies instead of animals for testing their products. End-use entities include academic research institutions, and various industries (such as pharmaceuticals, medical devices, chemicals & pesticides and cosmetics) performing animal testing to conduct basic research, toxicology profiling, and others. The non-animal testing market covered in this report includes sales of non-animal testing services by CROs to end use industries.

The market is inclusive of the costs of alternate technology tools and other operational costs involved in using these tools for various preclinical testing purposes.

Animal Testing And Non-Animal Testing Market Size

The global animal testing market was valued at $10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035.

Growth in the forecast period will result from the need for preclinical studies for the approval of therapeutics, increasing investment in R&D by the pharmaceutical companies, advances in genetic engineering, and the need for animal models to understand the complexity of biologics.

The global non-animal alternative testing market was valued at $1.11 billion in 2019.  The market is expected to grow at a CAGR of 10.40% during 2019-2025 and at a CAGR of 11.62% during 2025-2035.

Growth in the forecast period will result from increasing adoption of in-vitro and in-silico technologies in basic research by pharmaceutical industry, increasing adoption of non-animal testing technologies in preclinical research, government programs for non-animal alternative testing, ethical concerns on animal experimentations, high costs of animal studies, and increasing social awareness against animal cruelty.

Animal Testing Market Drivers

The key drivers of the animal testing market include:

The Need For Preclinical Studies For The Approval Of Therapeutics

The need for preclinical studies is on the rise as the researchers gain insights on new drug candidates’ dosing and toxicity while conducting these studies in animal models. Preclinical studies provide information about the safety and efficacy of a drug candidate before testing it in humans. The studies require appropriate preclinical models that are comparable to the target population to ensure reliable results. According to clinicalTrials.gov, a web-based resource which provides data on clinical studies, as of February 2020, there were 330,113 clinical studies registered, of which 34% were from the USA.  

With the growing need for drug discovery and development, the need for animal models in preclinical studies is also growing.  

Non-Animal Alternative Testing Market Drivers

The key drivers of the non-animal alternative testing market include:

Ethical Concerns On Animal Experimentations

Alternative animal testing technologies are increasingly adopted by the end-use industries due to the pressure from animal rights organizations such as PETA, and Cruelty-Free International to treat animals in an ethical way. These animal rights organizations are protesting and conducting media campaigns in order to stop animal physiological distress and suffering for research on drugs, cosmetic products, chemicals, and food ingredients. These organizations are working closely with government agencies, educational institutions, and end-use industries to provide funding for developing alternative technologies. Therefore, ethical concerns on animal experiments are creating new legislation in various countries thereby driving the alternative technologies market.  

Animal Testing Market Restraints

The key restraints on the animal testing market include:

The High Cost Of Animal Studies

The high cost associated with animal testing is challenging the growth of this market. The total cost of animal use in research studies is the sum of the cost of acquisition of the animals and that of maintaining the animals prior to and during their use. The maintenance cost and the actual cost for a particular species vary with the sex, strain, weight, age, quantity ordered, method of shipping, and distance shipped.  According to an animal supply company, New Zealand White Rabbits cost as high as $352 each, purebred Beagles for $1,049 and some primates costing more than $8,000 each.  Additionally, there is human labor cost, as the animals need an attendant.

The high cost of animal studies is hindering the animal testing market, and in a way boosting the adoption of alternative testing methods.

Non-Animal Alternative Testing Market Restraints

The key restraints on the non-animal alternative testing market include:

Regulatory Mandate On Animal Testing For Drug/Medical Device Approval

Regulatory authorities mandate animal testing for drug/medical approval in the pharmaceutical industry. Regulatory bodies such as the US Food and Drug Administration (FDA) follow the Animal Efficacy Rule, a regulation to approve products for further clinical studies based on safety and efficacy studies in animals.   The existence of animal testing regulation in the pharmaceutical industry is hindering the non-animal alternative testing market.

Non-Animal Alternative Testing Market Trends

Major trend influencing the non-animal alternative testing market include:

Increasing Collaborations & Partnerships To Reduce Animal Testing

End-use industries including cosmetics, pharmaceutical, medical devices, chemicals, and food companies are increasingly seeking partnerships and collaborations with the organizations involved in developing non-animal alternative testing technologies.   Collaborations of these end-use companies with leading scientists, academic research institutions, government agencies, and non-profit organizations help them better understand the industry requirements and bottlenecks in the deployment of these alternative technologies.

For instance, Unilever has collaborated with the US Environmental Protection Agency (EPA) to develop alternatives to animal testing strategies.  Since 2013, AstraZeneca has been collaborating with Emulate, Inc to develop organ-on-chip technology, which is expected to reduce the use of animals in research as well as the cost and time of discovery and development.  In a similar way, the Estee Lauder Companies recently expanded its partnership with cruelty-free international and humane society international to end animal testing in cosmetics.

Companies involved in non-animal testing should consider collaborating with end users to understand the industry requirements and bottlenecks.

Opportunities And Recommendations In The Animal Testing And Non-Animal Alternative Testing Market

Opportunities – The animal testing market size will gain the most in the ROW at $1.590 billion in 2025 and $2.314 billion in 2035.

The non-animal alternative testing market size will gain the most in Europe at $0.469 billion in 2025 and $1.456 billion in 2035.Market-trend-based strategies for the non-animal alternative testing market include collaborating with end users to understand the industry requirements and bottlenecks, and focusing on developing testing methods for the cosmetics industry to capitalize on increasing demand from the cosmetics industry. Player-adopted strategies in the non-animal alternative testing market include developing strategic partnerships and collaborations to expand R&D operations.

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the animal testing and non-animal alternative testing companies to focus on R&D to develop disease models , develop human-on-chip models, focus on pricing based on economies, focus on developing economies, use direct-to-consumer (DTC) advertising, collaborate with end user companies, and focus on people with specific diseases.

Animal Testing And Non-Animal Testing Market Segmentation

The animal testing market is segmented by type of end use industrial application, and by geography.
By End-Use - The animal market can be segmented by end-use industrial application into
    • a) Pharmaceuticals
    • b) Academic Research
    • c) Medical Devices
    • d) Chemicals & Pesticides
    • e) Cosmetics
    • f) Others

By Geography - The animal testing market is segmented into
    • o USA
    • o Japan
    • o China
    • o Australia
    • o France
    • o Canada
    • o UK
    • o Germany

By Geography - The non-animal alternative testing market is segmented into
    • o USA
    • o Japan
    • o Europe
    • o ROW

Non-Animal Alternative Testing Competitive Landscape

Major Competitors are:
    • • Emulate, Inc
    • • Organovo Holdings, Inc
    • • MatTek Corporation
    • • EMD Millipore
    • • China Tissue Engineering Co., Ltd. (J-TEC)
    • • ReproCell Inc
    • • Organ Technologies Co, Ltd
    • • Episkin
Other Competitors Include:
    • • Biochip
    • • Hurel Corporation
    • • Micronit
    • • Tara Biosystems
    • • BiomimX SRL
    • • Elveflow
    • • SynVivo
    • • BeonChip
    • • Mesobiotech
    • • Cherry Biotech
    • • 4DCell
    • • uFluidix Inc.
    • • CN Biosystems
    • • Hurel Corporation
    • • InSphero AG,
    • • Nortis Inc.
    • • HemoShear
    • • Ascendance Bio
    • • Organovo Holdings, Inc.

  1. 1. Animal Testing And Non-Animal Alternative Testing Executive Summary
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By End User Industry
  7. 7. Animal Testing And Non-Animal Alternative Testing Market Characteristics
    • 7.1.1. Animal Testing
    • 7.1.2. Non-Animal Alternative Testing
    • 7.1.3. Facts About Animals In Research - Functional Resemblances Of Animals To Human Body
  8. 8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis
    • 8.1.1. Animal Breeders and Suppliers
    • 8.1.2. Non-Animal Alternative Testing Technology Developers
    • 8.1.3. Regulatory Authorities
    • 8.1.4. Alternative Testing Service Providers
    • 8.1.5. End-Use Industries
  9. 9. Non-Animal Alternative Testing Trends
    • 9.1. Increasing Collaborations & Partnerships To Reduce Animal Testing
    • 9.2. Raising Investments And Research Grants For Developing Alternative Technologies
    • 9.3. Non-Animal Testing Methods In The Cosmetics Industry Are Gaining Traction
  10. 10. Cost Analysis For Animal Testing And Alternative Technologies
      • 10.1.1. Average Cost Of Laboratory Animals
      • 10.1.2. Average Cost Of Non-Animal Alternative Testing Methods
      • 10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
    • 10.2. Costs Involved In Animal Testing, 2018
  11. 11. Animal Testing And Non-Animal Alternative Testing Market Segments
    • 11.1. By End Use Industrial Application
      • 11.1.1. Important Areas of Use
      • 11.1.2. End-User Applications
    • 11.2. Animal Testing Market By Animal Type
      • 11.2.1. Mice
      • 11.2.2. Rat
      • 11.2.3. Frogs
      • 11.2.4. Fish
      • 11.2.5. Birds
      • 11.2.6. Guinea pig
      • 11.2.7. Hamster
      • 11.2.8. Rabbits
      • 11.2.9. Sheep
      • 11.2.10. Dogs
      • 11.2.11. Cats
      • 11.2.12. Monkeys
      • 11.2.13. Pigs
      • 11.2.14. Others
  12. 12. Number Of Animals Used In Research, By Country
    • 12.1.1. USA
    • 12.1.2. Europe
    • 12.1.3. United Kingdom (UK)
    • 12.1.4. Germany
    • 12.1.5. France
    • 12.1.6. Australia
    • 12.1.7. Canada
    • 12.1.8. China
  13. 13. Non-Animal Alternative Testing Technologies By Type And End Use
    • 13.1. Introduction
    • 13.2. Types Of Non-Animal Alternative Testing Technologies
      • 13.2.1. Cell Or Tissue Culture (In-Vitro)
      • 13.2.2. Organ-On-Chip (OOC)
      • 13.2.3. Global OOC Market Size And Growth
      • 13.2.4. Global OOC Market Drivers And Restraints
      • 13.2.5. Market Drivers
      • 13.2.6. Market Restraints
      • 13.2.7. In-silico (Computer-Based Models)
      • 13.2.8. Artificial Skin Models (Skin Substitutes)
      • 13.2.9. Other Technologies
  14. 14. End-User Industries Adoption To Alternative Testing Technologies
    • 14.1. Adoption of Alternative Testing Technologies By Type of Industry
      • 14.1.1. Cosmetics Industry
      • 14.1.2. Pharmaceutical Industry
      • 14.1.3. Medical Device Industry
      • 14.1.4. Others
    • 14.2. Adoption of 3R’s In USA
      • 14.2.1. 3R Adoption In The Cosmetics Industry
      • 14.2.2. 3R Adoption In The Pharmaceutical Industry
      • 14.2.3. 3R Adoption In The Medical Device Industry
    • 14.3. Adoption of 3R’s In China
      • 14.3.1. 3R Adoption In The Cosmetics Industry
      • 14.3.2. 3R Adoption In The Pharmaceutical Industry
      • 14.3.3. 3R Adoption In The Medical Device Industry
    • 14.4. Adoption of 3R’s In Europe
      • 14.4.1. 3R Adoption In The Cosmetics Industry
      • 14.4.2. 3R Adoption In The Pharmaceutical Industry
      • 14.4.3. 3R Adoption In The Medical Device Industry
  15. 15. Global Animal Testing And Non-Animal Testing Market
    • 15.1. Global Animal Testing Market Size And Growth
      • 15.1.1. Global Animal Testing Market Value ($ Billion)
      • 15.1.2. Global Animal Testing Market, By Volume (Million Units)
      • 15.1.3. Drivers Of The Animal Testing Market
      • 15.1.4. Restraints On The Animal Testing Market
    • 15.2. Global Non-Animal Alternative Testing Market Size And Growth
      • 15.2.1. Global Non-Animal Alternative Testing Market Value ($ Billion)
      • 15.2.2. Drivers Of The Non-Animal Alternative Testing Market
      • 15.2.3. Restraints On The Non-Animal Alternative Testing Market
  16. 16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis
  17. 17. USA Animal Testing And Non-Animal Alternative Testing Market
    • 17.1. USA Animal Testing Market
      • 17.1.1. USA Animal Testing Market Value ($ Billion)
      • 17.1.2. USA Animal Testing Market, By Volume (Million Units)
    • 17.2. USA Non-Animal Alternative Testing Market
      • 17.2.1. USA Non-Animal Alternative Testing Market Value ($ Billion)
    • 17.3. USA Animal Testing Market By End Use Industrial Application
      • 17.3.1. Market By Value And Volume
      • 17.3.2. Pharmaceuticals
      • 17.3.3. Academic Research industry was the second largest
      • 17.3.4. Medical Devices industry was the third largest
      • 17.3.5. Chemicals And Pesticides industry was the fourth largest
      • 17.3.6. Cosmetics industry was the smallest
      • 17.3.7. Other industries were the fifth largest
      • 17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
    • 17.4. Regulatory Landscape In The USA
      • 17.4.1. Regulatory Bodies & Policies
      • 17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
  18. 18. Japan Animal Testing And Non-Animal Alternative Testing Market
    • 18.1. Japan Animal Testing Market
      • 18.1.1. Japan Animal Testing Market Value ($ Billion)
      • 18.1.2. Japan Animal Testing Market, By Volume (Million Units)
    • 18.2. Japan Non-Animal Alternative Testing Market
      • 18.2.1. Japan Non-Animal Alternative Testing Market Value ($ Billion)
    • 18.3. Japan Animal Testing Market By End Use Industrial Application
      • 18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
    • 18.4. Regulatory Landscape In Japan
      • 18.4.1. Regulatory Bodies & Policies
      • 18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
  19. 19. China Animal Testing And Non-Animal Alternative Testing Market
    • 19.1. China Animal Testing Market
      • 19.1.1. China Animal Testing Market Value ($ Billion)
      • 19.1.2. China Animal Testing Market, By Volume (Million Units)
    • 19.2. Regulatory Landscape In China
      • 19.2.1. Regulatory Bodies & Policies
      • 19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
  20. 20. Australia Animal Testing And Non-Animal Alternative Testing Market
    • 20.1. Australia Animal Testing Market
      • 20.1.1. Australia Animal Testing Market Value ($ Billion)
      • 20.1.2. Australia Animal Testing Market, By Volume (Million Units)
    • 20.2. Regulatory Landscape In Australia
      • 20.2.1. Regulatory Bodies & Policies
      • 20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
  21. 21. Europe Animal Testing And Non-Animal Alternative Testing Market
    • 21.1. Regulatory Landscape In Europe
      • 21.1.1. EU Directive 2010/63
    • 21.2. Europe Non-Animal Alternative Testing Market
      • 21.2.1. Europe Non-Animal Alternative Testing Market Value ($ Billion)
  22. 22. France Animal Testing And Non-Animal Alternative Testing Market
    • 22.1. France Animal Testing Market
      • 22.1.1. France Animal Testing Market Value ($ Billion)
      • 22.1.2. France Animal Testing Market, By Volume (Million Units)
    • 22.2. France Animal Testing Market By End Use Industrial Application
      • 22.2.1. Market By Value And Volume
      • 22.2.2. Pharmaceuticals
      • 22.2.3. Academic Research industry was the second largest
      • 22.2.4. Chemicals & Pesticides industry was the third largest
      • 22.2.5. Medical Devices industry was the fourth largest
      • 22.2.6. Cosmetics industry was the smallest
      • 22.2.7. Other industries were the fifth largest
    • 22.3. Regulatory Landscape In France
      • 22.3.1. Regulatory Bodies & Policies
      • 22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
  23. 23. Germany Animal Testing And Non-Animal Alternative Testing Market
    • 23.1. Germany Animal Testing Market
      • 23.1.1. Germany Animal Testing Market Value ($ Billion)
      • 23.1.2. Germany Animal Testing Market, By Volume (Million Units)
    • 23.2. Germany Animal Testing Market By End Use Industrial Application
      • 23.2.1. Market By Value And Volume
      • 23.2.2. Pharmaceuticals
      • 23.2.3. Academic Research industry was the second largest
      • 23.2.4. Medical Devices industry was the third largest
      • 23.2.5. Chemicals And Pesticides industry was the fifth largest
      • 23.2.6. Cosmetics industry was the smallest
      • 23.2.7. Other industries were the fifth largest
    • 23.3. Regulatory Landscape In Germany
      • 23.3.1. Regulatory Bodies & Policies
      • 23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
  24. 24. UK Animal Testing And Non-Animal Alternative Testing Market
    • 24.1. UK Animal Testing Market
      • 24.1.1. UK Animal Testing Market Value ($ Billion)
      • 24.1.2. UK Animal Testing Market, By Volume (Million Units)
    • 24.2. UK Animal Testing Market By End Use Industrial Application
      • 24.2.1. Market By Value And Volume
      • 24.2.2. Pharmaceuticals
      • 24.2.3. Academic Research industry was the second largest
      • 24.2.4. Medical Devices industry was the third largest
      • 24.2.5. Chemicals & Pesticides industry was the fifth largest
      • 24.2.6. Cosmetics industry was the smallest
      • 24.2.7. Other industries were the fourth largest
    • 24.3. Regulatory Landscape in United Kingdom (UK)
      • 24.3.1. Regulatory Bodies & Policies
      • 24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
  25. 25. Canada Animal Testing And Non-Animal Alternative Testing Market
    • 25.1. Canada Animal Testing Market
      • 25.1.1. Canada Animal Testing Market Value ($ Billion)
      • 25.1.2. Canada Animal Testing Market, By Volume (Million Units)
    • 25.2. Regulatory Landscape In Canada
      • 25.2.1. Regulatory Bodies & Policies
      • 25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
  26. 26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
    • 26.1. Rest Of The World Animal Testing Market
      • 26.1.1. Rest Of The World Animal Testing Market Value ($ Billion)
      • 26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
    • 26.2. Rest of The World Non-Animal Alternative Testing Market
      • 26.2.1. Rest of The World Non-Animal Alternative Testing Market Value ($ Billion)
    • 26.3. Regulatory Landscape In Rest of the World (RoW)
      • 26.3.1. Regulatory Bodies & Policies
      • 26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
  27. 27. Competitive Landscape For Non-Animal Alternative Technologies
    • 27.1. USA Non-Animal Alternative Testing Market Competitive Landscape
      • 27.1.1. Emulate, Inc
      • 27.1.2. Organovo Holdings, Inc
      • 27.1.3. MatTek Corporation
      • 27.1.4. EMD Millipore
    • 27.2. China Non-Animal Alternative Testing Market Competitive Landscape
      • 27.2.1. China Tissue Engineering Co., Ltd. (J-TEC)
      • 27.2.2. ReproCell Inc
      • 27.2.3. Organ Technologies Co, Ltd
    • 27.3. Europe Non-Animal Alternative Testing Market Competitive Landscape
      • 27.3.1. Episkin
  28. 28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
    • 28.1. Global Animal Testing Market In 2035 – Geographies Offering Most New Opportunities
    • 28.2. Global Non-Animal Alternative Testing Market In 2035 – Geographies Offering Most New Opportunities
    • 28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 – Segments Offering Most New Opportunities
    • 28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2023 – Growth Strategies
      • 28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
      • 28.4.2. Competitor Strategies
  29. 29. Conclusions & Recommendations
    • 29.1. Conclusions
    • 29.2. Recommendations
      • 29.2.1. Product
      • 29.2.2. Price
      • 29.2.3. Place
      • 29.2.4. Promotion
      • 29.2.5. People
      • 29.2.6. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries
      • 29.2.7. Increasing Number Of Players In The Non-Animal Alternative Testing Market
      • 29.2.8. Focus On Developed Countries
      • 29.2.9. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion
  30. 30. Appendix
    • 30.1. Glossary
    • 30.2. Market Data Sources
    • 30.3. Research Methodology
      • 30.3.1. OCED Accepted In Vito Tests
    • 30.4. Survey on Animal Models & Testing Landscape in the US
      • 30.4.1. Current Condition By Company
      • 30.4.2. Number Of Animals Used In Testing
    • 30.5. Expert Interviews List
    • 30.6. Non Animal Alternative Testing Interviews
    • 30.7. USA Interviews
      • 30.7.1. Interview 1
      • 30.7.2. Interview 2
      • 30.7.3. Interview 3
      • 30.7.4. Interview 4
      • 30.7.5. Interview 5
      • 30.7.6. Interview 6
      • 30.7.7. Interview 7
      • 30.7.8. Interview 8
      • 30.7.9. Interview 9
    • 30.8. China Interviews
      • 30.8.1. Interview 10
      • 30.8.2. Interview 11
      • 30.8.3. Interview 12
      • 30.8.4. Interview 13
      • 30.8.5. Interview 14
      • 30.8.6. Interview 15
    • 30.9. Animal Testing Interviews
      • 30.9.1. Interview 16
      • 30.9.2. Interview 17
      • 30.9.3. Interview 18
      • 30.9.4. Interview 19
      • 30.9.5. Interview 20
      • 30.9.6. Interview 21
      • 30.9.7. Interview 22
  31. 31. Interview 23

List Of Tables

    Table 1: Average Cost Of Animals, 2018 ($)
  • Table 2: Estimated Cost Analysis For Animal Testing And Non-Animal Alternative Testing Methods, 2018 ($)
  • Table 3: Number of Animals Used in Research in the US, 2017
  • Table 4: Number of Animals Used in Research, UK, 2018
  • Table 5: Number of Animals Used in Research, Germany, 2018
  • Table 6: Animal Used by species Group, Germany, (% Share), 2018
  • Table 7: Number of Animals Used in Research, France, 2017
  • Table 8: Cell Culture As An Alternative to Animal Testing, Major Cell Culture Developers Worldwide
  • Table 9: Global OOC Market, Historic Market Size, 2015 – 2019, $ Million
  • Table 10: Global OOC Market, Historic Market Size, 2015 – 2019, $ Million
  • Table 11:  Organ-On-Chips As An Alternative To Animal Testing, Major OOC Developers Worldwide
  • Table 12: Computer Simulation As An Alternative to Animal Testing, Major In-Silico Model Developers
  • Table 13: Artificial Skin Model As An Alternative To Animal Testing, Major Artificial Skin Model Developers
  • Table 14: Non-Animal Alternative Testing Methods Accepted By The US Agencies
  • Table 15: Non-Animal Alternative Testing Methods Accepted By The China Agencies
  • Table 16: Non-Animal Alternative Testing Methods Accepted By The European Commission
  • Table 17: Global Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 18: Global Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 19: Global Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion
  • Table 20: USA Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 21: USA Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 22: USA Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion
  • Table 23: USA Animal Testing Market, By End Use Industrial Application, By Value ($ Billion), And By Volume (Millions) 2019,
  • Table 24: USA Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018
  • Table 25: Laboratory Animal Testing Regulatory Landscape In The USA
  • Table 26: Japan Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 27: Japan Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 28: Japan Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion
  • Table 29: Japan Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018
  • Table 30: Laboratory Animal Testing Regulatory Landscape In Japan
  • Table 31: China Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 32: China Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 33: Laboratory Animal Testing Regulatory Landscape In China
  • Table 34: Australia Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 35: Australia Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 36: Laboratory Animal Testing Regulatory Landscape In Australia
  • Table 37: Europe Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion
  • Table 38: France Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 39: France Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 40: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Table 41: Laboratory Animal Testing Regulatory Landscape In France
  • Table 42: Germany Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 43: Germany Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 44: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Table 45: Laboratory Animal Testing Regulatory Landscape In Germany
  • Table 46: UK Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 47: UK Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 48: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Table 49: Laboratory Animal Testing Regulatory Landscape In The UK
  • Table 50: Canada Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 51: Canada Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 52: Laboratory Animal Testing Regulatory Landscape In Canada
  • Table 53: Rest Of The World Animal Testing Market Size, 2019 – 2035, $ Billion
  • Table 54: Rest Of The World  Animal Testing Market, Volume, 2019– 2035, Million Units
  • Table 55: Rest Of The World Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion
  • Table 56: Laboratory Animal Testing Regulatory Landscape In RoW
  • Table 57: Emulate Inc, Product Portfolio
  • Table 58: Emulate Inc, Product & Services
  • Table 59: Organovo, Product Portfolio
  • Table 60: MatTek, Product Portfolio
  • Table 61: EMD Millipore, Product Portfolio
  • Table 62: J-TEC, Product Portfolio
  • Table 63: ReproCell, Product Portfolio
  • Table 64: Organ Technologies Product Portfolio
  • Table 65: Episkin, Product Portfolio
  • Table 66: Global Animal Testing Market Size Gain ($ Billion), 2019 – 2023, By Country
  • Table 67: Global Non-Animal Alternative Market Size Gain ($ Billion), 2019 – 2023, By Country
  • Table 68: Global Animal Testing  And Non-Animal Alternative Testing Market Size Gain ($ Billion), Segmentation By Type, 2019 – 2035
  • Table 69: Market Data Sources
  • Table 70: OECD Accepted In-Vitro Tests For Medical Devices
  • Table 71: Number Of Animals Tested Globally in 2018
  • Table 72: Expert Interviews List

List Of Figures

    Figure 1: Global Animal Testing And Non-Animal Alternative Testing Market Size And Growth Comparison
  • Figure 2: Global Growth Of Non-Animal Alternative Testing Market By Country
  • Figure 3: Global Animal Testing Market Segmentation By End User Industry
  • Figure 4: Value Chain Analysis For Animal Testing & Non-Animal Alternative Testing Market
  • Figure 5: Statistics of Scientific Procedures on Living Animals in the UK, 2018
  • Figure 6: Animal Used by Species Group, 2018, (%) (i) Re-use (II) Excludes Re-use
  • Figure 7:  Global OOC Market, Historic Market Size, 2015 – 2019, $ Million
  • Figure 8:  Global OOC Market, Forecast Market Size, 2019 – 2023, $ Million
  • Figure 9: Animal Testing & Non-Animal Alternative Testing Share In The Major End-Use Industries
  • Figure 10:  Global Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 11:  Global Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 12:  Global Non-Animal Alternative  Testing Market Size, 2019 – 2035, $ Billion
  • Figure 13: USA Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 14: USA Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 15:  USA Non-Animal Alternative  Testing Market Size, 2019 – 2035, $ Billion
  • Figure 16:  USA Animal Testing Market, By End Use Industrial Application, By Value ($ Billion), And By Volume (Millions) 2019
  • Figure 17: Japan Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 18: Japan Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 19:  Japan Non-Animal Alternative  Testing Market Size, 2019 – 2035, $ Billion
  • Figure 20: China Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 21: China Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 22: Australia Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 23: Australia Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 24:  Europe Non-Animal Alternative  Testing Market Size, 2019 – 2035, $ Billion
  • Figure 25: France Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 26: France Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 27:  France Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Figure 28: Germany Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 29: Germany Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 30:  Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Figure 31: UK Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 32: UK Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 33:  UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, $ Billion
  • Figure 34: Canada Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 35: Canada Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 36: Rest Of The World Animal Testing Market Size, 2019 – 2035, $ Billion
  • Figure 37: Rest Of The World Animal Testing Market, Volume, 2019 – 2035, Million Units
  • Figure 38:  Rest of The World Non-Animal Alternative  Testing Market Size, 2019 – 2035, $ Billion
Increase In Outsourcing At Accounting Firms Yields Greater Client Satisfaction
Robotics And Drones In Forensic Auditing!
International Collaborations And Economic Growth Are Driving The Design Services Market
John Wood Group And Altran Technologies Are Market Leaders For Design Services
High Demand For Industrial Design Services From Large Manufacturing Industries
Management Consulting Industry Trends- Emergence Of Virtual Firms And IT Transformation
Use Of Artificial Intelligence In The Forensic Audit Services Industry
Big Data Analytics And The Use Of 3D Printing Technology In The Specialized Design Services Market
Engineering Services Global Market Report 2020-30: Covid 19 Impact and Recovery
View Report
Advertising Agencies Global Market Report 2020-30: COVID 19 Growth And Change
View Report
Public Opinion And Election Polling Global Market Report 2020-30: COVID 19 Growth And Change
View Report
Billboard And Outdoor Advertising Global Market Report 2020-30: Covid 19 Growth And Change
View Report
Biotechnology Services Global Market Report 2020-30: Covid 19 Growth And Change
View Report
Digital Advertising Global Market Report 2020-30: Covid 19 Growth And Change
View Report
Direct Mail Advertising Global Market Report 2020-30: Covid 19 Growth And Change
View Report
HR Advisory Services Global Market Report 2020-30: Covid 19 Growth And Change
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)